$16.30 · Score 39/100
Open-market buy and sell transactions (Form 4) by directors, officers, and beneficial owners of Janux Therapeutics, Inc., sourced directly from SEC EDGAR.
No insider transactions recorded for JANX in our data yet — this list fills in gradually as the site is browsed and refreshes the feed from SEC EDGAR.
This information is based on official filings only and does not constitute investment advice. Insider transactions don't necessarily signal a stock's future direction — they can often stem from personal cash-flow needs, portfolio diversification, or tax planning.
